Foot News and Research

RSS

New Herman & Walter Samuelson Children's Hospital at Sinai to be dedicated on March 1

The new Herman & Walter Samuelson Children's Hospital at Sinai will be dedicated on Thursday, March 1. The 23,200-square-foot facility features 26 all-private rooms that support the very heart of the family-centered care philosophy. This method of care embraces the family as an integral part of the child's treatment and recovery. The family works alongside the clinical team to ensure the best outcomes for their sick child.

23 Feb 2012

Contraception opinions: We're all Catholics now, a sex tax? And the 'safe, legal, rare' illusion

Because when the state comes against the Catholics, or the Jews, or the Muslims, or the Pentecostals, or the Mormons or those of any other faith – exotic or familiar – we must all stand up as one: We are all Catholics now. ... Perhaps this is a hard line. But when it comes to the separation of church and state, we need absolutes.

22 Feb 2012

Equinix, Carpathia Hosting partner to build new data center for healthcare companies, federal agencies

Equinix, Inc., a provider of global data center services, and Carpathia Hosting, a provider of complex, compliant managed hosting services for government agencies and enterprises, today announced plans to build a 64,000 square foot data center in Dulles, Va. aimed at supporting industry-specific compliant solutions for healthcare companies, federal agencies, and commercial industries.

21 Feb 2012

Apixio introduces Clinical Knowledge Exchange at HIMSS 2012 conference

Apixio, Inc., the leading provider of clinical data integration, search and analytics for healthcare organizations, is introducing this week at the HIMSS 2012 conference, a technology framework called the Clinical Knowledge Exchange.

20 Feb 2012

Innocoll completes XaraColl End-of-Phase 2 meeting with FDA

Innocoll, Inc. announced that it has held an End-of-Phase 2 meeting with the FDA to present the results of the Phase 2 clinical studies completed for XaraColl and to discuss the proposed safety and efficacy studies to be conducted in Phase 3. XaraColl is being developed for postoperative analgesia and Innocoll plans to undertake its Phase 3 program in patients undergoing hernia repair.

17 Feb 2012

Good surveillance system for FMD can minimize economic losses to Mexican cattle industry

In a worst-case scenario simulation of a foot-and-mouth disease outbreak in Mexico, researchers found that establishing a good surveillance system and raising a more resilient breed of cattle could lessen the blow to the Mexican cattle industry should an outbreak of foot-and-mouth disease (FMD) or other infectious disease occur.

17 Feb 2012

Despite fewer amputations, Medicare's bill for artificial feet rises 60%

The Associated Press examines the complicated issue of health costs by looking at foot amputations from diabetes.

16 Feb 2012

The U.S. debates the contraception rule

A selection of opinions and editorials on the controversy surrounding the administration's regulation mandating insurance coverage for women of birth control.

14 Feb 2012

DARPA awards fourth milestone payment of $3.56M to Medicago

Medicago USA Inc., a wholly owned subsidiary of Medicago Inc., a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced it has received the fourth milestone payment of US$3.56 million from the Defense Advanced Research Projects Agency.

13 Feb 2012

Simple, innovative program can detect and prevent falls among seniors

It's a scenario played out all too frequently: Adult children, worried about the safety of their aging parents, foist devices on them to monitor their safety. And their parents, resentful of having their privacy invaded and losing their independence, resist fiercely.

8 Feb 2012

$Female soccer players more likely to suffer stress fracture or ligament injury$

Female soccer players more likely to suffer stress fracture or ligament injury

In the U.S., there are nearly three million youth soccer players, and half of them are female. New research presented today at the 2012 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) found that despite reporting appropriate body perception and attitudes toward eating, elite youth soccer athletes (club level or higher) face an increased risk for delayed or irregular menstruation.

8 Feb 2012

Hitachi Aloka Medical releases F37 digital diagnostic ultrasound system

Hitachi Aloka Medical, Ltd. announced the release of a new digital diagnostic ultrasound system, F37. F37 was developed focusing on contributing to primary care, such as in clinics and examination institutions.

8 Feb 2012

Anticoagulation drugs can prevent PE, DVT after total joint replacement

Following a total joint replacement, anticoagulation (blood thinning) drugs can prevent Deep Vein Thrombosis (DVT), a blood clot deep within the extremities, or a pulmonary embolism (PE), a complication that causes a blood clot to move to the lungs.

7 Feb 2012

Immune cells from healthy individuals effectively kill cancer cells

Immune cells from healthy individuals can be the new immune cure for cancer. This treatment can kill cancer cells without destroying neighbouring cells. The hope is to eradicate cancer for ever.

3 Feb 2012

The Methodist Hospital now offers advanced rehabilitation system for treatment of foot drop

The Methodist Hospital Outpatient Rehabilitation Center now offers an advanced rehabilitation system for the treatment of foot drop in people with mobility issues caused by stroke, traumatic brain injury, multiple sclerosis, cerebral palsy and spinal cord injury.

2 Feb 2012

Gottlieb to open new health center in the near west suburbs

Gottlieb Memorial Hospital is opening a new health center designed around the needs of patients in the near west suburbs. The Gottlieb Center for Immediate Care at River Forest, 7617 W. North Ave., is part of the Loyola University Health System. Physicians from both the Loyola Maywood and the Gottlieb Melrose Park campuses will together care for patients at the nearly 10,000 square-foot new facility.

31 Jan 2012

Watson plans to establish Global R&D Technology Center in North Brunswick

Watson Pharmaceuticals, Inc. today announced plans to establish a Global R&D Technology Center in North Brunswick, New Jersey.

30 Jan 2012

Inlyta receives FDA approval for treatment of advanced kidney cancer

The U.S. Food and Drug Administration today approved Inlyta (axitinib) to treat patients with advanced kidney cancer (renal cell carcinoma) who have not responded to another drug for this type of cancer.

30 Jan 2012

FTC terms Omnicare's proposed acquisition of PharMerica illegal

The Federal Trade Commission issued a complaint to block Omnicare, Inc.'s hostile acquisition of rival long-term care pharmacy provider PharMerica Corporation, alleging that the combination of the two largest U.S. long-term care pharmacies would harm competition and enable Omnicare to raise the price of drugs for Medicare Part D consumers and others.

30 Jan 2012